alive and kicking
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks. Still on vacation, now at Pismo Beach, but I still check in and appreciate your digging. 80 degrees and sunny with humongous waves!
Does the big price drop today mean Foley will announce a largge batch of new lower priced stock options to reward excellent performance and reatin quality management including himself. I sure as hell never saw a stock price drop to $11 from the mid $30s about 4 months ago and after Daxxify approval for the CD indication. Will anyone in senior management pay a price or will it be business as usual?
I thought the guy hadn’t used Daxxify yet.
What concerns? You mean from the anonymous group you couldn’t or wouldn’t provide a link to?
From your recent posts you don’t seem to be up on Daxxify as you didn’t know about the price cut. Why should we take your word that you have some inside scoop?
Management better be touting the approval in CD and put forth their strategy to show a timely and broad based marketing in this indication.
dewophile,
I agree with you. ENTA could just keep the product listed in development without spending any appreciable amount of money on it.
Thanks for the correction. The bigger and more important issue is that the barrier for resistance is quite low for fusion inhibitors. It is astonishing, at least to me, to see resistance arising during a trial.
ENTA's chat with Wells Fargo yesterday was valuable and informative......, well, if you knew nothing about ENTA.
The questions asked were mostly about RSV.
The Wells Fargo chat yesterday was valuable and informative......, well, if you knew nothing about ENTA.
The questions asked were mostly about RSV.
Good news for SGEN shareholders as the PFE buyout is likely to be approved too.
https://www.cnbc.com/2023/09/01/ftc-allows-amgen-horizon-therapeutics-deal-to-move-forward.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard